Un año MASC: Reflexiones sobre esta normativa y sus oportunidades

This article analyses the first year of application of the adequate dispute resolution mechanisms introduced by Organic Law 1/2025 and reflects on the opportunities that this new regulatory framework may offer pharmaceutical companies in the field of civil and commercial litigation.